Remove Marketing Remove Medical science Remove Physicians
article thumbnail

What Physicians Want from Pharma—And Where—During Diagnosis and Treatment

PM360

For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions.

article thumbnail

8 Tactics to Increase HCP Engagement in 2024

PM360

A series of studies and surveys have documented the fact that substantial numbers of physicians, nurses, and allied health professionals are active on or prefer social media for professional purposes and to connect directly with peers. AI will also help marketers determine what works and what doesn’t.

Media 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Digital Patient Intake is Revolutionizing Healthcare

Referral MD

While medical science advances, too many clinics still rely on cumbersome paperwork. From reducing paperwork headaches to ensuring doctors have accurate, up-to-date patient data, they quietly transform how physicians deliver care. We live in a world of instant communication and on-demand services.

article thumbnail

5 Quick Tips for MSL When Engaging KOLs

Clarity Engagement Solutions

The primary purpose of Medical Science Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. We have highlighted 5 quick tips for MSL to aid them through the process when engaging with KOL’s.

article thumbnail

Biologic Prices Decreasing As More Commercial Health Plans Allow Biosimilars as First-Line Options

PM360

When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. So, that’s quite the hurdle for access, I think.

article thumbnail

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Medgadget

This new way of controlling laparoscopic tools the company describes as “endo-robotic surgery” Its leadership sees it as being able to disrupt the existing market, thanks to significant cost reductions, all while offering surgeons capabilities previously only available from very expensive robotic systems.

article thumbnail

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Clarify Health

Each drug on the market started off as an idea that successfully overcame many hurdles while thousands (and sometimes millions) of other potential therapies failed along the way. After FDA-approval comes the last critical mile of this journey: bringing the product to market. sales, medical science liaisons, etc.).